63402-115 : Kynmobi 15 mg Sublingual Film, Soluble


NDC63402-115
Labeler: Sunovion Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Kynmobi
Dosage Form: Sublingual Film, Soluble
Application #: NDA210875
Rev. Date: 


NDC Package Codes:

  • 63402-115-30: 30 POUCH IN 1 CARTON (63402‑115‑30) > 1 FILM, SOLUBLE IN 1 POUCH (63402‑115‑01)

Active Ingredients:

  • Apomorphine Hydrochloride

Dosage Strength:

  • 15 mg

Pharmaceutical Classes:

  • Dopamine Agonists [MoA]
  • Dopaminergic Agonist [EPC]

Related Products:

Based on records with the same trade name.
  • 63402-010 Kynmobi 10 mg Sublingual Film, Soluble by Sunovion Pharmaceuticals Inc.
  • 63402-015 Kynmobi 15 mg Sublingual Film, Soluble by Sunovion Pharmaceuticals Inc.
  • 63402-020 Kynmobi 20 mg Sublingual Film, Soluble by Sunovion Pharmaceuticals Inc.
  • 63402-025 Kynmobi 25 mg Sublingual Film, Soluble by Sunovion Pharmaceuticals Inc.
  • 63402-030 Kynmobi 30 mg Sublingual Film, Soluble by Sunovion Pharmaceuticals Inc.
  • 63402-088 KynmobiKynmobi Sublingual Kit by Sunovion Pharmaceuticals Inc.
  • 63402-110 Kynmobi 10 mg Sublingual Film, Soluble by Sunovion Pharmaceuticals Inc.
  • 63402-120 Kynmobi 20 mg Sublingual Film, Soluble by Sunovion Pharmaceuticals Inc.
  • 63402-125 Kynmobi 25 mg Sublingual Film, Soluble by Sunovion Pharmaceuticals Inc.
  • 63402-130 Kynmobi 30 mg Sublingual Film, Soluble by Sunovion Pharmaceuticals Inc.
  • 63402-188 KynmobiKynmobi Sublingual Kit by Sunovion Pharmaceuticals Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63402-115 QR Code

< Prev: 63402-110Next: 63402-120 >

Related Discussions:





Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.